Itraconazole Oral Solution as Prophylaxis for Fungal Infections in Neutropenic Patients with Hematologic Malignancies: A Randomized, Placebo‐Controlled, Double‐Blind, Multicenter Trial

Menichetti, Francesco, Del Favero, Albano, Martino, Piero, Bucaneve, Giampaolo, Micozzi, Alessandra, Girmenia, Corrado, Barbabietola, Giuliana, Pagano, Livio, Leoni, Pietro, Specchia, Giorgina, Caiozzo, Alessandro, Raimondi, Roberto, Mandelli, Franco, the GIMEMA Infection Program·1999·Clinical Infectious Diseases
DOI 10.1086/515129

Cited by (244)

Items 101–200 of 244

  1. The changing spectrum of candidemia in oncology patients: therapeutic implications
    Kieren A. Marr · 2000 · Current Opinion in Infectious Diseases
  2. Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients
    Nashaat S. Hamza, Mahmoud Afif Ghannoum, H M Lazarus · 2004 · Bone Marrow Transplantation
  3. Fungal Infections in Patients With Neutropenia
    Raoul Herbrecht, S??gol??ne Neuville, V. Letscher‐Bru, Shanti Natarajan‐Amé, Olivier Lortholary · 2000 · Drugs & Aging
  4. Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review
    Petros Pechlivanoglou, Hoa H. Le, Simon M. G. J. Daenen, John Andrew Snowden, Maarten Jacobus Postma · 2013 · Journal of Antimicrobial Chemotherapy
  5. Infection in Hematopoietic Stem Cell Transplantation
    Michael Boeckh, Kieren A. Marr · 2002 · Springer eBooks
  6. Association between Antifungal Prophylaxis and Rate of Documented Bacteremia in Febrile Neutropenic Cancer Patients
    Claudio Viscoli, Marianne Paesmans, Miguel Ángel Sanz, Elio Castagnola, Jean A. Klastersky, P. Martino, Michel Pierre Glauser · 2001 · Clinical Infectious Diseases
  7. Infections in solid organ transplant recipients
    Nina Singh · 1998 · Current Opinion in Infectious Diseases
  8. Determination of Itraconazole and Hydroxyitraconazole in Plasma by Use of Liquid Chromatography-Tandem Mass Spectrometry with On-line Solid-Phase Extraction
    Michael Vogeser, Ute Spöhrer, Xaver Schiel · 2003 · Clinical Chemistry and Laboratory Medicine (CCLM)
  9. THE CURRENT MANAGEMENT OF INFECTIOUS DISEASES IN THE LIVER TRANSPLANT RECIPIENT
    Nina Singh · 2000 · Clinics in Liver Disease
  10. Pneumonia in Acute Leukemia Patients During Induction Therapy: Experience in a Single Institution
    Giorgina Specchia, Domenico Pastore, Paola Carluccio, Giuseppe Mele, Maria Teresa Montagna, Arcangelo Liso, Rita Rizzi, Amatoantonio Stabile Ianora, Vincenzo Liso · 2002 · Leukemia & lymphoma/Leukemia and lymphoma
  11. INVASIVE ASPERGILLOSIS IN CHILDREN: UPDATE ON CURRENT GUIDELINES
    Athanasia Apsemidou, Nikolaos Petridis, Timoleon‐Achilleas Vyzantiadis, Athanasios Tragiannidis · 2018 · Mediterranean Journal of Hematology and Infectious Diseases
  12. New agents for the treatment of systemic fungal infections – current status
    John H. Rex, Sevtap Arıkan · 2002 · Expert Opinion on Emerging Drugs
  13. Interventions for preventing oral candidiasis for patients with cancer receiving treatment
    Jan Clarkson, Helen V Worthington, Tim O.B. Eden · 2007 · Cochrane Database of Systematic Reviews
  14. Invasive candidiasis and candidaemia in neonates and children: update on current guidelines
    Athanasios Tragiannidis, Christos Tsoulas, Andreas H. Groll · 2014 · Mycoses
  15. New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies
    Helen L. Leather, John R. Wingard · 2006 · Blood Reviews
  16. The role of primary antifungal prophylaxis in patients with haematological malignancies
    Livio Pagano, Morena Caira · 2013 · Clinical Microbiology and Infection
  17. New agents for treatment of systemic fungal infections
    Sevtap Arıkan, John H. Rex · 2000 · Emerging Drugs
  18. Prophylaxis and treatment of fungal infections associated with haematological malignancies
    Sibel Aşçıoğlu · 2000 · International Journal of Antimicrobial Agents
  19. Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia
    Kürşat Kaptan, Ali Uğur Ural, Türker Çetin, Ferit Avcu, Cenǵiz Beyan, Atilla Yalçın · 2003 · Journal of Infection and Chemotherapy
  20. ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
    Vazquez, Lourdes · 2016 · Mediterranean Journal of Hematology and Infectious Diseases
  21. Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies
    Yuji Hirata, Taiji Yokote, Kichinosuke Kobayashi, Shoko Nakayama, Satoko Oka, Takuji Miyoshi, Toshikazu Akioka, Nobuya Hiraoka, Kazuki Iwaki, Ayami Takayama et al. · 2010 · Leukemia & lymphoma/Leukemia and lymphoma
  22. Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials
    Cho‐Hao Lee, Chin S. Lin, Ching‐Liang Ho, Jung‐Chung Lin · 2018 · Antimicrobial Agents and Chemotherapy
  23. Primary Antifungal Prophylaxis in Adult Hematopoietic Stem Cell Transplant Recipients: Current Therapeutic Concepts
    Dorothy McCoy, Daryl D. DePestel, Peggy L. Carver · 2009 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  24. Therapeutic Guidelines in Systemic Fungal Infections
    Richardson, Jones Bl · 2003
  25. Antifungal prophylaxis in pediatric patients undergoing therapy for cancer
    Thomas Lehrnbecher · 2015 · Current Opinion in Infectious Diseases
  26. Polymerase chain reaction aids in the diagnosis of an unusual case of Aspergillus niger endocarditis in a patient with acute myeloid leukaemia
    D McCracken, Rosemary A. Barnes, C Poynton, Philip Lewis White, N Işik, D S Cook · 2003 · Journal of Infection
  27. Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
    Jean El Cheikh, Luca Castagna, Ling Wang, Benjamin Esterni, Catherine Faucher, Sabine Fürst, Ségolène Duran, Pierre Berger, Stéphane Ranque, Mohamad Mohty et al. · 2010 · Hematology/Oncology and Stem Cell Therapy
  28. Clinical pharmacology of antifungal agents in pediatric patients
    Christine C. Chiou, Thomas J. Walsh, Andreas H. Groll · 2007 · Expert Opinion on Pharmacotherapy
  29. Antifungal prophylaxis in hematopoietic stem cell transplant recipients
    Kieren A. Marr · 2001 · Current Opinion in Infectious Diseases
  30. The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients
    Pamela J. Paterson, Paul H. M. McWhinney, Michael N Potter, Christopher C. Kibbler, Hugh Grant Prentice · 2001 · British Journal of Haematology
  31. Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high‐risk myelodysplastic syndrome undergoing induction chemotherapy
    Gloria N. Mattiuzzi, Hagop M. Kantarjian, Susan Mary O'Brien, Dimitrios P. Kontoyiannis, Francis Joseph Giles, Xian Zhou, Joann T. Lim, Benjamin Nebiyou Bekele, Stefan H Faderl, Jörge E. Cortes et al. · 2004 · Cancer
  32. Antimicrobial Prophylaxis in Febrile Neutropenia
    Minoru Yoshida, Ryuzo Ohno · 2004 · Clinical Infectious Diseases
  33. Reflections on the Approach to Treatment of a Mycologic Disaster
    David A. Stevens · 2013 · Antimicrobial Agents and Chemotherapy
  34. Infections in the Cancer Patient
    Oscar Marchetti, Frédéric Tissot, Thierry Calandra · 2016 · Elsevier eBooks
  35. Candida
    María Cecilia Dignani, Joseph S. Solomkin, Elias J. Anaissie · 2009 · Elsevier eBooks
  36. The Role of Itraconazole in Preventing and Treating Systemic Fungal Infections in Immunocompromised Patients
    Michael N Potter, J. Peter Donnelly · 2004 · Acta Haematologica
  37. Invasive mycoses in organ transplant recipients: controversies in prophylaxis and management
    Navreet Singh · 2000 · Journal of Antimicrobial Chemotherapy
  38. Effectiveness of Systemic Antifungal Prophylaxis in Patients With Neutropenia After Chemotherapy: A Meta-Analysis of Randomized Controlled Trials
    Panayiotis D. Ziakas, Irene S. Kourbeti, Michael Voulgarelis, Eleftherios E Mylonakis · 2010 · Clinical Therapeutics
  39. Prophylactic Administration of Liposomal Amphotericin B Is Superior to Treatment in a Murine Model of Invasive Aspergillosis after Hematopoietic Cell Transplantation
    Andrew BitMansour, Janice Wes Brown · 2002 · The Journal of Infectious Diseases
  40. Preventative use of antifungal drugs in patients treated for cancer
    Ben de Pauw · 2004 · Journal of Antimicrobial Chemotherapy
  41. Tratamiento de las infecciones fúngicas en pacientes con neoplasias hematológicas
    José Mensa, Rafael de la Cámara, Enric Carreras, Manuel Cuenca Estrella, José Ángel García Rodríguez, M Gobernado, Juan Picazo, José María Aguado, Miguel Ángel Sanz · 2009 · Medicina Clínica
  42. Drugs Active against Fungi, Pneumocystis, and Microsporidia
    John H. Rex, David A. Stevens · 2015 · Elsevier eBooks
  43. Emerging issues in nosocomial fungal infections
    Cristiana M. Toscano, William Robert Jarvis · 1999 · Current Infectious Disease Reports
  44. Pathogen ‘shift’ in febrile neutropenia
    Christopher C. Kibbler, Hugh Grant Prentice · 1999 · Current Opinion in Infectious Diseases
  45. Fungal Infections in the Immunocompromised Host
    Lawrence Joseph Wheat, Mitchell Goldman, George A. Sarosi · 2002 · Springer eBooks
  46. Infections in solid organ transplant recipients
    Nina Singh · 2000 · Current Opinion in Infectious Diseases
  47. Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients
    Nikolaos G. Almyroudis, Brahm H. Segal · 2010 · Expert Review of Anti-infective Therapy
  48. Tratamiento antifúngico empírico en pacientes seleccionados con fiebre persistente y neutropenia
    José Miguel Cisneros, Ildefonso Espigado, Antonio Rivero, Fernando Lozano de León, Jorge Parra, Antonio Collado, José Manuel Lomas, Jerónimo Pachón · 2005 · Enfermedades Infecciosas y Microbiología Clínica
  49. Systemic Antifungal Agents
    John H. Rex, David A. Stevens · 2010 · Elsevier eBooks
  50. Prevention and prophylaxis of invasive fungal sinusitis in the immunocompromised patient
    Preeti Malani, Carol A. Kauffman · 2000 · Otolaryngologic Clinics of North America
  51. Febrile neutropenia in allogeneic transplantation
    Robrecht De Bock, A.Z. Middelheim · 2000 · International Journal of Antimicrobial Agents
  52. Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies
    Huilan Zeng, Zhuman Wu, Bing Yu, Bo Wang, Chengnian Wu, Jie Wu, Jing Lai, Xiaoyan Gao, Jie Chen · 2021 · BMC Cancer
  53. Controversies in Antimicrobial Prophylaxis
    Ben de Pauw, Marta Stanzani · 2011 · Humana Press eBooks
  54. Oral antifungals as prophylaxis in haematological malignancy
    Archie Prentice, P. Donnelly · 2001 · Blood Reviews
  55. Systemic Antifungal Agents
    Shmuel Shoham, Andreas H. Groll, Vidmantas Petraitis, Thomas J. Walsh · 2016 · Elsevier eBooks
  56. Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study
    Sharat Chandra, Tsuyoshi Fukuda, Kana Mizuno, Stella M. Davies, Ashley Teusink‐Cross, Richard Tarin, Rebecca A Marsh, Alexander A. T. M. M. Vinks, Parinda A. Mehta · 2018 · Journal of Antimicrobial Chemotherapy
  57. Emerging therapeutic agents for onychomycosis
    Gérald Pierard, Jorge E. Arrese, Pascale Quatresooz, C Piérard-Franchimont · 2007 · Expert Opinion on Emerging Drugs
  58. Itraconazole Prophylaxis for Invasive Gingival Aspergillosis in Neutropenic Patients With Acute Leukemia
    Yoshinari Myoken, Tatsumi Sugata, Taiichi Kyo, Megumu Fujihara, Yuzuru Mikami · 2002 · Journal of Periodontology
  59. Infection in the neutropenic and haematopoietic stem cell transplant recipient
    J. Peter Donnelly · 2000 · Current Opinion in Infectious Diseases
  60. Advances in systemic antifungal therapy
    David A. Stevens · 2012 · Clinics in Dermatology
  61. Antifungal agents in preventing oral candidiasis in clinical oncology: A network meta‐analysis
    Yee Shen Loo, Tse Yee Wong, Sajesh Kalkandi Veettil, Pei Se Wong, Divya Gopinath, Siew Mooi Ching, Rohit Kunnath Menon · 2020 · Oral Diseases
  62. Antifungals: Drug Class, Mechanisms of Action, Pharmacokinetics/Pharmacodynamics, Drug-Drug Interactions, Toxicity, and Clinical Use
    Jeniel E. Nett, David R. Andes · 2014 · ASM Press eBooks
  63. COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis
    Jonas Frost, Maximilian Gornicec, Alexander Christian Reisinger, Philipp Eller, Martin Hoenigl, Juergen Prattes · 2024 · Mycopathologia
  64. Itraconazole for invasive fungal infection with pediatric malignancies
    Ryōji Kobayashi, Daisuke Suzuki, Kazue Yasuda, Kunihiko Kobayashi · 2010 · Pediatrics International
  65. Antifungal Prophylaxis in Neutropenic Patients with Hematologic Malignancies
    A. B�hme, Meinolf Karthaus, David T. Hoelzer · 1999 · KARGER eBooks
  66. Fungal Infections in Patients with Solid Tumors Treated with High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation
    Jesús Montesinos, C. Sola, Pablo Maroto, Ramón Salazar, Judith Balmañà, Amaia Ramírez, B. Pardo, Roser Pericas, Mercè Gurguí, José López‐López · 2001 · European Journal of Clinical Microbiology & Infectious Diseases
  67. Antifungal strategies for managing invasive aspergillosis: The prospects for a pre-emptive treatment strategy
    Catherine Orla Morrissey, Monica A. Slavin · 2006 · Medical Mycology
  68. The use of itraconazole as prophylaxis against invasive fungal infection in blood and marrow transplant recipients
    Breida Boyle, Shaun R. McCann · 2000 · Transplant Infectious Disease
  69. Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
    Kieren A. Marr · 2001 · PubMed
  70. Management of Infections in Leukemia and Lymphoma
    Lowell S. Young · 2002 · Springer eBooks
  71. Clinical Significance of Measuring the Blood Concentration of Itraconazole Oral Solution in the Field of Hematology
    Sadahiko Shimoeda, Saori Nakagawa, Hikaru Kobayashi, Susumu Yamato, Kenji Kawano, Shin Ohta · 2010 · Biological and Pharmaceutical Bulletin
  72. Established and Emerging Oral Antifungals in Dermatology
    Gérald Pierard, C Piérard-Franchimont, Valérie Vroome, Jorge Arrese, Pascale Quatresooz, Marcel J. Borgers, Geert Cauwenbergh · 2007 · CRC Press eBooks
  73. Primary Antifungal Prophylaxis with Low-Dose Intravenous Amphotericin B in Hematological Malignancies. Results of a Pilot Study
    Angelika Böhme, David T. Hoelzer · 2000 · Oncology Research and Treatment
  74. Febrile neutropenia: antifungal prophylaxis
    J. Peter Donnelly · 2000 · International Journal of Antimicrobial Agents
  75. Improving the conduct and reporting of clinical trials
    E Wager, J A Tumas, E A Field, N B Glazer, G Schulz, L Grossman · 2000 · PubMed
  76. Infection in the neutropenic and stem cell transplant patient
    Jean A. Klastersky · 1999 · Current Opinion in Infectious Diseases
  77. Oral Fluconazole for Empiric Treatment of Prolonged Fever in Neutropenic Patients
    Salomon Marcello Stemmer, ‪Yasmin Maor‬‏, Izhar Hardan · 2004 · American Journal of Clinical Oncology
  78. Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents
    A.K. Due, Helle Krogh Johansen, Peter Christian Gøtzsche · 2006 · BMC Medical Research Methodology
  79. Therapeutic drug monitoring for antifungal triazoles: pharmacologic background and current status
    Andreas H. Groll, Silke Gastine · 2019 · Handbook of analytical separations
  80. Correlation of in vitro activity and in vivo efficacy of itraconazole intravenous and oral solubilized formulations by testing Candida strains with various itraconazole susceptibilities in a murine invasive infection
    Katsuhisa Uchida, K. Shimogawara, Hiroki Yamaguchi · 2010 · Journal of Antimicrobial Chemotherapy
  81. How to Improve the Design of Trials of Antifungal Prophylaxis among Neutropenic Adults with Acute Leukemia
    Francesco Menichetti · 2004 · Clinical Infectious Diseases
  82. Interventions for preventing oral candidiasis for patients with cancer receiving treatment
    Helen V Worthington, Osborn B. Eden, Jan Clarkson · 2004 · Cochrane Database of Systematic Reviews
  83. Infections associated with neutropenia and transplantation
    Emmanuel Q. Wey, C Kibbler · 2010 · Elsevier eBooks
  84. Clinical Pharmacology of Itraconazole in Children and Adolescents
    Efi Drogouti, Zoi Dorothea Pana, Athanasios Tragiannidis, Georg Hempel, A. H. Groll · 2015 · Current Fungal Infection Reports
  85. Antifungal agents
    Shmuel Shoham, Andreas H. Groll, Thomas J. Walsh · 2010 · Elsevier eBooks
  86. Monitoring and Prophylaxis.
    Minoru Yoshida · 2001 · Nippon Ishinkin Gakkai Zasshi
  87. Prophylaxis against fungal infections and cytomegalovirus disease after bone marrow transplantation.
    Aimee Wilkin, Judith Feinberg · 2000 · PubMed
  88. Economic evaluation of the prevention and management of systemic fungal infections in neutropenic patients
    Karen Moeremans, Lieven Annemans · 2006 · Expert Opinion on Pharmacotherapy
  89. Infektionen
    Andreas H. Groll, Arne Simon, Thomas Lehrnbecher · 2005 · Springer eBooks
  90. Infecciones en pacientes oncohematológicos no trasplantados
    M.C. Mateos, José-María Arguiñano, M.A. Ardaiz, Francisco Jose Oyarzabal · 2005 · Anales del Sistema Sanitario de Navarra
  91. Use of antifungal agents in the intensive care unit
    Magnús Gottfreðsson, John R. Perfect · 1999 · Current Opinion in Critical Care
  92. Therapy for fungal infections in leukemia
    Robert E. Segal, Grace Y. Minamoto · 2001 · Current Oncology Reports
  93. Antifungal prophylaxis in neutropenia
    Johan A. Maertens, Marc Boogaerts · 1999 · Current Opinion in Infectious Diseases
  94. Medical cost analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: a systematic simulation analysis
    Osamu Imataki, Yoshitsugu Kubota, Hiroaki Ohnishi, Akira Kitanaka, Toshihiko Ishida, Terukazu Tanaka · 2010 · Supportive Care in Cancer
  95. Infectious Complications in Kidney Transplantation
    Amr A El-Husseini, Rashad Hass · 2011 · InTech eBooks
  96. Advances in the management of invasive fungal infections in organ transplant recipients: step by step
    Ben E. De Pauw · 2000 · Transplant Infectious Disease
  97. Profilaxis antifúngica en pacientes oncohematológicos: revisión de la bibliografía médica y recomendaciones
    Rafael de la Cámara, José Mensa, Enric Carreras, Manuel Cuenca Estrella, José Ángel García Rodríguez, M Gobernado, Juan Picazo, José María Aguado, Miguel Ángel Sanz · 2009 · Medicina Clínica
  98. Infecciones en el paciente oncológico
    María Soledad Maldonado Regalado · 2013 · Revista española de pediatría
  99. Cord blood transplantation and cord blood banking.
    Shunichi Kato · 2005 · PubMed
  100. Aspergilosis invasora en el paciente con enfermedad oncohematológica
    Carlos Solano, Lourdes Vázquez · 2018 · Revista Iberoamericana de Micología